Search Results - "Brakenhoff, J.P.G"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Pharmacokinetic profile of a modified release formulation of trimetazidine (TMZ MR 35 mg) in the elderly and patients with renal failure by Barré, J., Ledudal, P., Oosterhuis, B., Brakenhoff, J.P.G., Wilkens, G., Sollie, F.A.E., Tran, D.

    Published in Biopharmaceutics & drug disposition (01-05-2003)
    “…Objectives – To study the effect of age and renal function on the pharmacokinetic profile of a modified release tablet of trimetazidine (TMZ MR 35 mg)…”
    Get full text
    Journal Article
  2. 2

    Toxicity of fotemustine in rat hepatocytes and mechanism-based protection against it by Vermeulen, N.P.E, Commandeur, J.N.M, Groot, E.J, Wormhoudt, L.W, Ramnatshing, S, Li, Q.J, Brakenhoff, J.P.G

    Published in Chemico-biological interactions (03-04-1998)
    “…Fotemustine is a relatively novel DNA-alkylating 2-chloroethyl-substituted N-nitrosourea (CENU) drug, clinically used for the treatment of disseminated…”
    Get full text
    Journal Article
  3. 3

    Nephrotoxicity of mercapturic acids of three structurally related 2,2-difluoroethylenes in the rat. Indications for different bioactivation mechanisms by Commandeur, J N, Brakenhoff, J P, De Kanter, F J, Vermeulen, N P

    Published in Biochemical pharmacology (01-12-1988)
    “…The biotransformation and the hepato- and nephrotoxicity of the mercapturic acids (N-acetyl-1-cysteine S-conjugates) of three structurally related…”
    Get more information
    Journal Article
  4. 4

    High-throughput solid-phase extraction for the determination of cimetidine in human plasma by Hempenius, J, Wieling, J, Brakenhoff, J.P.G, Maris, F.A, Jonkman, J.H.G

    “…For the implementation and validation of an automated `high-throughput' solid-phase extraction (SPE) system, using microtiter solid-phase technology and a…”
    Get full text
    Journal Article